Paul Brown: Phase III Trial Supports SRS for SCLC Brain Metastases
Paul Brown/X

Paul Brown: Phase III Trial Supports SRS for SCLC Brain Metastases

Paul Brown, Professor of Radiation Oncology and Consultant in the Department of Radiation Oncology at Mayo Clinic, shared on X:

“Randomized Trial ASTRO26 Small Cell Lung Cancer Brain Met fractionated SRS vs HA-WBRT

  •  No diff time to cognitive failure, neurologic death
  • SRS, OS
  • AEs HA-WBRT
  • SRS standard of care SCLC brain met”

Paul Brown: Phase III Trial Supports SRS for SCLC Brain Metastases

You can also read: Breast Cancer Brain Metastases Harbor Actionable Genomic Alterations: Could the Brain Lesion Become a Precision-Oncology Target?

Paul Brown: Phase III Trial Supports SRS for SCLC Brain Metastases